Some pharmacodynamic effects of eformoterol in the horse

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 5, 2007, Pages 496-499

  Ladaga, G J B ^a,b   Lezica, F P ^a   Ferraro, G ^c   De Erausquin, G A ^a,d  

^a Grupo INCA   (Argentina)

^b Laboratorio Fundación   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEROL; FORMOTEROL; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; DRUG SENSITIVITY; HORSE; HUMAN; LUNG HEMORRHAGE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

ANIMALS; AREA UNDER CURVE; BRONCHODILATOR AGENTS; ETHANOLAMINES; FEMALE; HEART RATE; HORSES; INJECTIONS, INTRAMUSCULAR; MALE; RESPIRATION;

EQUIDAE;

EID: 34548451131     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00882.x     Document Type: Article

References (20)

1. Advenier, C., Qian, Y., Koune, J.D., Molimard, M., Candenas, M.L. Naline, E. (1992) Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig. British Journal of Pharmacology, 105, 792 798.
2. Baluk, P. McDonald, D.M. (1994) The beta 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. American Journal of Physiology, 266 (4 Pt 1 L461 468.
3. Barnes, P.J. (1993) Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells. Life Sciences, 52, 2101 2109.
4. Faulds, D., Hollingshead, L.M. Goa, K.L. (1991) Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs, 42, 115 137.
5. Greiff, L., Wollmer, P., Andersson, M., Svensson, C. Persson, C.G. (1998) Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax, 53, 1010 1013.
6. Hoffman, B.B. Lefkowitz, R.J. (1982) Agonist interactions with alpha-adrenergic receptors. Journal of Cardiovascular Pharmacology, 4 (Suppl. 1 S14 18.
7. Ida, H. (1976) Comparison of the action of BD 40 A and some other beta-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig. Arzneimittelforschung, 26, 839 842.
8. Ida, H. (1980) [General pharmacology of (alpha RS)-3-formamido-4-hydroxy- alpha-[[[(alpha RS)-p-methoxy-alpha-methylphenethyl]amino]methyl] benzyl alcohol fumarate dihydrate (BD 40A), a new bronchodilator agent]. Nippon Yakurigaku Zasshi, 76, 633 654.
9. Kawakami, Y. (1984) Evaluation of therapeutic effects of formoterol, a b-adrenoceptor stimulating bronchodilator, on bronchial asthma. A multicenter double-blind single-dosis study. Clinical Evaluation, 12, 697 727.
10. Ladaga, G.J.B., Pont Lezica, F., Ulloa, F., de Erausquin, G.A., Ruzzante, G., Negrelli, C. del Carril, R. (2003) Evaluation of the efficacy of eformoterol on exercise-induced pulmonary hemorrhage in training thoruoughbred horses. Online Journal of Veterinary Research, 7, 99 105.
11. Lecaillon, J.B., Kaiser, G., Palmisano, M., Morgan, J. Della Cioppa, G. (1999) Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer. European Journal of Clinical Pharmacology, 55, 131 138.
12. Lindberg, S., Khan, R. Runer, T. (1995) The effects of formoterol, a long-acting beta 2-adrenoceptor agonist, on mucociliary activity. European Journal of Pharmacology, 285, 275 280.
13. Mita, H. Shida, T. (1983) Anti-allergic activity of formoterol, a new beta-adrenoceptor stimulant, and salbutamol in human leukocytes and human lung tissue. Allergy, 38, 547 552.
14. Nightingale, J.A., Rogers, D.F. Barnes, P.J. (1999) Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. American Journal of Respiratory and Critical Care Medicine, 159, 1786 1790.
15. Nishikori, K. Maeno, H. (1979) Characterization of beta-adrenergic receptor and adenylate cyclase in canine cerebellum. Archives of Biochemistry and Biophysics, 195, 505 517.
16. O'Donnell, S.R. Anderson, G.P. (1995) The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo. British Journal of Pharmacology, 116, 1571 1576.
17. 2+ transients and changes in the cell volume and microviscosity of the plasma membrane in smooth muscle cells. Evaluation of the effect of formoterol. Biochemical Pharmacology, 52, 49 63.
18. Takeda, M. Takagi, T. (1980) [Effects of a new bronchodilator, (alpha RS)-3-formamido-4-hydroxy-alpha-[[[(alpha RS)-p-methoxy-alpha-methylphenethyl] amino] methyl] benzyl alcohol fumarate dihydrate (BD 40A) on gastric acid secretion and gastrointestinal motility]. Nippon Yakurigaku Zasshi, 76, 185 191.
19. Verleden, G.M., Belvisi, M.G., Rabe, K.F., Miura, M. Barnes, P.J. (1993) Beta 2-adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. Journal of Applied Physiology, 74, 1195 1199.
20. Zink, S., Rosen, P. Lemoine, H. (1995) Micro- and macrovascular endothelial cells in beta-adrenergic regulation of transendothelial permeability. American Journal of Physiology, 269 (5 Pt 1 C1209 1218.